NeoGraph Analytics
Medical ImagingNorth America2023 – 2032

Global North America Medical Imaging AI Market Analysis, Opportunities and Forecast 2024-2032

North America Medical Imaging AI market valued at $1.5B in 2023, projected to reach $10.77B by 2032 at 24.5% CAGR.

Revenue, 2023

$1.5B

Forecast, 2032

$10.8B

CAGR, 2024-2032

24.5%

Report Coverage

North America

Code: north-america-medical-imaging-ai-marketPublished: 2026Pages: 150+Format: PDF + Excel
01

Executive Summary

The North America Medical Imaging AI market was valued at $1.5 billion in 2023 and is projected to reach $10.77 billion by 2032, growing at a CAGR of 24.5%. North America commands approximately 45% of the global medical imaging AI market, driven by advanced healthcare infrastructure, high radiology volumes, and strong regulatory pathways. Key growth is fueled by AI-assisted diagnostics in radiology, cardiology, and oncology. Leading players include NVIDIA, Siemens Healthineers, and Aidoc. Investment opportunities are strongest in cloud-based imaging platforms and point-of-care AI solutions.

02

Key Highlights

1

Market projected to grow from $1.5B to $10.77B at 24.5% CAGR through 2032

2

CT imaging AI leads modality segmentation with 25% market share

3

Radiology applications dominate end-use demand accounting for 30% of segment

03

Market Overview

Market Context

The North America Medical Imaging AI market is in a high-growth phase driven by radiologist shortages, rising chronic disease burden, and accelerating FDA approvals for AI-based diagnostic tools. Hospitals and diagnostic centers are primary adopters, with cloud-based deployment models gaining preference.

The North America Medical Imaging AI market is experiencing rapid growth, driven by rising imaging volumes, radiologist shortages, and FDA-cleared AI algorithms. The market reached $1.5 billion in 2023 and is set to exceed $10.77 billion by 2032. Radiology and cardiology applications dominate adoption.

Market Stage

High growth

Adoption Level

Growing

Key Trends

FDA-cleared AI algorithms accelerating clinical adoption across radiology departmentsCloud-based imaging AI platforms reducing infrastructure costs for mid-size hospitalsIntegration of generative AI for automated radiology report drafting gaining tractionPoint-of-care ultrasound AI expanding into emergency and primary care settings
04

Market Forecast & Data

Market Growth Forecast
2024-2032 · CAGR 24.5%

Base Year (2023)

$1.5B

Forecast (2032)

$10.8B

CAGR (2024-2032)

24.5%

Market size by year, 2024-2032, in USD Billion.
YearMarket size ($ Billion)
2023Base year$1.50B
2024$1.87B
2025$2.33B
2026$2.89B
2027$3.60B
2028$4.49B
2029$5.59B
2030$6.95B
2031$8.66B
2032$10.78B
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
Forecast Analysis

The market is forecast to grow ninefold from $1.5B to $10.77B by 2032. CT and radiology segments will lead growth. The United States will remain the dominant market while ambulatory care settings represent the fastest-growing end-user segment.

Regional Market Analysis
Market share and growth rate by region
Regional market analysis — market share, growth rate and largest market by region.
RegionMarket shareGrowth rateLargest market
North America45.0%24.5%United States
Europe30.0%22.0%Germany
Asia Pacific25.0%28.0%China

North America

#1
Share: 45.0%CAGR: 24.5%

Largest market: United States

Europe

#2
Share: 30.0%CAGR: 22.0%

Largest market: Germany

Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
05

Market Dynamics

  • Increasing radiologist shortage driving demand for AI-assisted diagnostics
  • Rising imaging volumes due to aging population and chronic disease prevalence
  • FDA expedited clearance pathways enabling faster AI algorithm approvals
06

Market Segmentation

By Modality
Market share distribution across 6 segments
By Modality — market share by segment, in percent.
SegmentShare
CTLargest segment driven by AI-powered detection of lung nodules, brain hemorrhages, and cardiac abnormalities.25.0%
MRIGrowing adoption of AI for cardiac MRI quantification and neuroimaging analysis.22.0%
X-rayWidely deployed AI for chest X-ray screening and fracture detection in emergency settings.20.0%
UltrasoundEmerging segment with AI-guided point-of-care ultrasound gaining traction in primary care.15.0%
MammographyAI-assisted breast cancer screening gaining regulatory approvals and clinical adoption.10.0%
PETAI-enhanced PET imaging for oncology staging and treatment response monitoring.8.0%
Total100.0%
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
By Application
Market share distribution across 5 segments
By Application — market share by segment, in percent.
SegmentShare
RadiologyDominant application area with broad AI deployment across chest, abdominal, and neuroimaging.30.0%
OncologyAI-driven tumor detection, segmentation, and treatment monitoring across multiple modalities.22.0%
CardiologyAI for cardiac imaging including ejection fraction measurement and coronary artery analysis.20.0%
NeurologyStroke detection, brain tumor analysis, and neurodegenerative disease screening applications.15.0%
OrthopedicsAI-assisted fracture detection and musculoskeletal imaging analysis gaining clinical traction.13.0%
Total100.0%
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.

By End User

  • Hospitals
  • Diagnostic Centers
  • Research Institutes
07

Regional Analysis

1

North America

Lead: United States
CAGR: 24.5%Share: 45.0%

Largest market globally driven by advanced healthcare IT infrastructure, high imaging volumes, and strong FDA pipeline.

2

Europe

Lead: Germany
CAGR: 22.0%Share: 30.0%

Growing adoption supported by EU MDR framework and increasing AI integration in radiology departments.

3

Asia Pacific

Lead: China
CAGR: 28.0%Share: 25.0%

Fastest-growing region driven by massive imaging demand, government healthcare digitization initiatives, and AI startup proliferation.

Country-Level Analysis

Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
Market share and growth rate by country
CountryShareGrowth
United States
40.0%
+24.5%
Germany
15.0%
+21.0%
China
18.0%
+30.5%
08

Competitive Landscape

N

NVIDIA

United States

Leader27B

Dominates medical imaging AI infrastructure through Clara platform and GPU-accelerated computing for diagnostic imaging.

Global leader in GPU-accelerated computing providing the Clara medical imaging AI platform for radiology, pathology, and drug discovery applications.

A

Aidoc

Israel

Challenger150M

Fast-growing AI startup with multiple FDA clearances for acute findings in radiology including pulmonary embolism and intracranial hemorrhage.

Leading clinical AI company with multiple FDA clearances focused on detecting acute abnormalities in radiology workflows.

A

Arterys

United States

Follower

Specializes in cloud-native cardiac and lung imaging AI with FDA-cleared quantification tools for MRI and CT.

Also profiled

S

Siemens Healthineers

22B

Major medical technology company integrating AI-powered imaging solutions across CT, MRI, and molecular imaging platforms globally.

09

Recent Developments

25
2025NVIDIA

Launched Clara AI platform 4.0 with expanded support for 50+ imaging models and federated learning capabilities

24
2024Aidoc

Received FDA 510(k) clearance for AI algorithm detecting collapsed lung conditions, expanding its radiology portfolio to 15+ clearances

10

Regulatory Landscape

FDA AI/ML-Based Software as a Medical Device (SaMD) Action Plan providing framework for predetermined change control plansU.S. HHS Office of the National Coordinator for Health IT (ONC) final rule requiring EHR systems to support AI and CDS interoperability
11

Research Methodology

Primary research

  • Expert interviews with radiologists and hospital IT directors
  • Surveys of healthcare technology procurement officers

Secondary research

  • Industry analyst reports from IDC and Gartner
  • Company financial filings and investor presentations

Validation: Triangulation method

12

Strategic Takeaways

Investors

The 24.5% CAGR presents strong VC and PE opportunities in diagnostic AI startups and imaging infrastructure plays.

Operators

Prioritize cloud-native AI platforms and radiology workflow integration to capture growing hospital demand.

Policymakers

Regulatory frameworks like FDA SaMD are enabling faster market entry while ensuring clinical safety standards.

Technology vendors

Interoperability with existing PACS and EHR systems is critical for successful market penetration.

13

Frequently Asked Questions

Reports in the same field, each with its base-year figure and the growth rate it is published at.